Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$11.35 - $13.6 $1.32 Million - $1.58 Million
-116,022 Reduced 99.25%
882 $11.9 Million
Q3 2023

Nov 13, 2023

BUY
$12.38 - $13.69 $1.45 Million - $1.6 Million
116,904 New
116,904 $1.46 Billion
Q2 2023

Aug 14, 2023

BUY
$13.13 - $14.17 $1.36 Million - $1.47 Million
103,490 New
103,490 $1.4 Million
Q2 2019

Aug 13, 2019

SELL
$15.54 - $17.47 $614,793 - $691,148
-39,562 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$15.5 - $17.9 $248 - $286
16 Added 0.04%
39,562 $678,000
Q4 2018

Feb 14, 2019

BUY
$13.99 - $20.35 $515,853 - $750,365
36,873 Added 1379.46%
39,546 $598,000
Q2 2018

Aug 14, 2018

BUY
$18.13 - $19.4 $48,461 - $51,856
2,673 New
2,673 $50,000
Q4 2017

Feb 14, 2018

SELL
$18.31 - $22.24 $1,263 - $1,534
-69 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$20.12 - $21.88 $20 - $21
1 Added 1.47%
69 $1,000
Q2 2017

Aug 14, 2017

BUY
N/A
68
68 $1,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Thomas J. Herzfeld Advisors, Inc. Portfolio

Follow Thomas J. Herzfeld Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.